Cefepime and New Cefepime/Beta-Lactamase Inhibitor Combination for the Treatment of Gram-Negative Bacteria: Chemical Structure and Mechanism of Action, Microbiological Target, Clinical Use and PK/PD Characteristics

The global spread of multidrug-resistant (MDR) Gram-negative bacteria, particularly extended-spectrum β-lactamase (ESBL)- and carbapenemase-producing <i>Enterobacterales</i>, <i>Pseudomonas aeruginosa</i>, and <i>Acinetobacter baumannii</i>, presents a significant public health challenge by limiting...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Davide Carcione, Gioconda Brigante, Antonella Carducci, Jari Intra, Simone Ambretti, Floriana Campanile, Gabriele Arcari, Nicasio Mancini, Dario Cattaneo, Floriana Gona, Mariagrazia Perilli, Alessandra Piccirilli, Nicholas Geremia, Verena Zerbato, Stefano Di Bella, Giovanna Maria Nicolò, Luigi Principe
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	MDPI AG 2026-02-01
Saila:	Pharmaceuticals
Gaiak:	cefepime β-lactam/β-lactamase inhibitor (BL/BLI) combinations zidebactam taniborbactam enmetazobactam nacubactam
Sarrera elektronikoa:	https://www.mdpi.com/1424-8247/19/2/283
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!